Vaxart Inc
VXRT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$104.42M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $104.42 Million |
|---|---|
| Enterprise Value | $61.36 Million |
| Earnings per Share | $0.07 |
| Beta | 1.06 |
| Outstanding Shares | 242,165,410 |
Return
| Return on Equity | 46.85% |
|---|---|
| Return on Assets | 23.36% |
| Return on Invested Capital | 48.24% |
Valuation & Multiples
| P/E Ratio | 2.87 |
|---|---|
| PEG | -28.79 |
| Price to Sales | 0.4 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.25 |
| Enterprise Value to EBIT | 1.38 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$-0.17
Consensus analyst estimateRevenue Estimate
$26.21 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.03
Consensus analyst estimateRevenue Estimate
$27.20 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.02% |
|---|---|
| Total Invested | $4,502▼ 88.46% |
| Investors Holding | 1▼ 4.00% |
About Vaxart Inc
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using tablets that can be stored and shipped wit...